# CXCL10high Microglia in Cerebral Malaria: Toward Translational Validation

## TL;DR

The paper suggests that a specific type of microglia, marked by high CXCL10, may play a role in cerebral malaria and needs further validation in human studies.

## Contribution

The paper proposes a cautious approach to interpreting microglia as a new neuroimmune endotype in cerebral malaria, emphasizing the need for translational validation.

## Key findings

- CXCL10high TNFαhigh Ki67+ microglia are linked to CD8+ T cell recruitment in experimental cerebral malaria.
- Translational validation of these microglia requires human postmortem tissue analysis and biomarker correlation.
- Strong therapeutic claims based on experimental models alone are cautioned against.

## Abstract

Wang et al. identify CXCL10high TNFαhigh Ki67+ microglia as drivers of CD8+ T cell recruitment during experimental cerebral malaria (ECM). We propose a conservative reframing: rather than asserting a fully validated new taxonomy, CXCL10high microglia should be considered a candidate “neuroimmune endotype” whose translational relevance requires clearly prespecified and testable validation in human disease. Priority validation steps include single‐nucleus and spatial transcriptomics of human postmortem tissue, paired plasma/CSF biomarker correlation, and mechanistic assays of microglial antigen presentation. We caution against strong therapeutic inferences from ECM alone; translational work should first establish reproducible human microglial signatures and clinical correlations before precision‐targeted interventions are proposed.